Mariella Purvis, PA
Medical · Washington, DCNPI 1023179751
Payments from drug & device makers
Across 551 payments — averaging $24.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$2K
- Pfizer$1K
- UCB, Inc.$1K
- AbbVie$1K
- Johnson & Johnson$1K
- Novartis$995
- plus $6K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 41 | $2,112 |
| Pfizer | 59 | $1,249 |
| UCB, Inc. | 54 | $1,246 |
| AbbVie | 58 | $1,199 |
| Johnson & Johnson | 33 | $1,030 |
| Novartis | 57 | $995 |
| Amgen | 34 | $923 |
| E.r. Squibb & Sons, L.L.C. | 36 | $850 |
| Incyte Corporation | 43 | $762 |
| Sanofi | 21 | $642 |
| Lilly USA, LLC | 22 | $460 |
| Galderma Laboratories, L.p. | 20 | $377 |
| Arcutis Biotherapeutics, Inc. | 12 | $267 |
| LEO Pharma Inc. | 12 | $260 |
| Sun Pharmaceutical Industries Inc. | 12 | $226 |
| Verrica Pharmaceuticals Inc. | 8 | $138 |
| Dermavant Sciences, Inc. | 6 | $125 |
| Organon | 2 | $93 |
| Boehringer Ingelheim | 3 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Botanix SB Inc | 3 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| Journey Medical Corporation | 2 | $45 |
| Kyowa Kirin, Inc. | 2 | $45 |
| Revance Therapeutics, Inc. | 1 | $35 |
| LNHC, Inc | 1 | $24 |
| Almirall LLC | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| VYNE Pharmaceuticals Inc. | 1 | $14 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $13 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
How this compares
$13,453 in reported general payments places this provider in the 95th percentile of 87 medical providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Washington
- Annise Williams-NairnWashington$8K
- Teylor MartinezWashington$6K
- Hannah SagedyWashington$5K
- Amanda-Gay EdwardsWashington$4K
- Albertina DearingWashington$4K
- Gwendolyn ChallengerWashington$4K
- Susan LelacheurWashington$4K
- Melanie Scott BowlingWashington$3K
- Connor ButzWashington$3K
- Samineh AsgariWashington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.